G R Boss, J E Seegmiller. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAllopurinol/therapeutic useArthritis/drug therapyArthritis/metabolismAspirin/adverse effectsColchicine/therapeutic useCoronary Disease/etiologyDiuretics/adverse effectsGout/classificationGout/diagnosisGout/drug therapyHumansHypoxanthine Phosphoribosyltransferase/deficiencyIndomethacin/therapeutic useKidney/physiologyKidney Calculi/etiologyKidney Diseases/etiologyLead Poisoning/complicationsLymphoproliferative Disorders/complicationsMyeloproliferative Disorders/complicationsPhenylbutazone/therapeutic usePlatelet AggregationProbenecid/therapeutic usePurine-Pyrimidine Metabolism, Inborn Errors/complicationsPyrazinamide/adverse effectsRibose-Phosphate Pyrophosphokinase/deficiencyRibose-Phosphate Pyrophosphokinase/metabolismUric Acid/bloodUric Acid/metabolismUric Acid/urineUricosuric Agents/therapeutic use
Substances: See more » DiureticsUricosuric AgentsUric AcidPyrazinamideAllopurinolHypoxanthine PhosphoribosyltransferaseRibose-Phosphate PyrophosphokinasePhenylbutazoneProbenecidAspirinColchicineIndomethacin
Year: 1979 PMID: 221806 DOI: 10.1056/NEJM197906283002604
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245